Insider filing · PCVX
Grant Pickering
CHIEF EXECUTIVE OFFICER
profile →
Vaxcyte, Inc.
PCVX · Healthcare · 41 filings in 24 months
ticker →
Grant Pickering sold $1.2M of Vaxcyte (PCVX)
Executed Jun 18, disclosed Jun 18, the same day.
Value, as filed
$1.2M
22,236 sh × $52.50
Executed
Jun 18
the trade date, as filed
Disclosed
Jun 18
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GPGrant Pickering (CHIEF EXECUTIVE OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $1.2M of PCVX (22,237 sh across 3 lots, as filed), executed Jun 26.
The name
PCVXHealthcare · Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial inf…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Grant Pickering in PCVX
PCVXSALE
Vaxcyte, Inc.
$901K16,198 sh across 2 lots
Exec Jul 27
Filed Jul 28 · 4:10 PM ET PCVXSALE Vaxcyte, Inc. $1.2M
22,237 sh across 3 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. $1.4M
15,000 sh across 3 lots
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. $1.6M
15,000 sh across 3 lots
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. $434K
3,962 sh across 2 lots
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. $6.3M
55,000 sh across 9 lots
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET